Product Details
Rufenac Gel 1%+++
Diclofenac Sodium (Diclofenac Diethylamine); Methyl salicylate; Menthol1.16%; 3%; 2%
Gel
ROA
Topical
Applicant Name
Shalina Healthcare Nigeria Limited
NRN
A4-6124
Status
Active
Composition
Rufenac Gel contains: Diclofenac Diehthylammonium Salt 1.16% w/w equivalent to Diclofenac Sodium BP 1.0% w/w, Methyl Salicylate BP 3.0% w/w and Menthol BP 2.0% w/w Excipients: Acrypol 980 In-House, Acrysol 140 USP/NF, Disodium Edetate BP, Methyl Hydroxy Benzoate (Methyl Paraben) BP, Propyl Hydroxy Benzoate (Propyl Paraben) BP, Triethanolamine BP and Purified water (q.s) BP
ATC Code
M01AB55
Product Category
Drugs
Marketing Category
Over-the-counter (OTC)
Packsize
1 x 30 g (in Aluminium tube)
Product Description
Topical gel 86 RNW-PP-375327 RUFENAC GEL 1% Diclofenac Diehthylammonium salt 1.16% w/w equivalent to Diclofenac sodium BP 1.0% w/w, Methyl Salicylate BP 3.0% w/w & Menthol BP 2.0% w/w. Diclofenac Dimethylammonium salt 1.16% w/w equivalent to Diiclofenac Sodium BP 1.0% w/w, Methyl Salicylate Bp 3.0% w/w & menthol BP 2.0& w/w. Excipients- Disodium Edetate BP, Methyl Hydroxy Benzoate BP, Propyl Hydroxy Benzoate BP, Triethanolamine BP, Polyoxyl 40 Hydrogenated Castor oil USNF, Carbomer 980 USNF A4-6124 Drugs Imported Products 1*30grams Over The Counter (OTC) 10/19/2023 SHALINA HEALTHCARE NIGERIA LIMITED, FATAI ATERE WAY, MATORI MUSHIN LAGOS LAGOS GOLPALDAS VISRAM & CO., LTD., PLOT NO.A590/591, T.T.C INDUSTRIAL AREA,MIDC MAHAPE, NAVI MUMBAI, THANE 400701 MAHARASHTRA STATE, INDIA., India
Manufacturer Name
GOLPALDAS VISRAM & CO., LTD
Manufacturer Country
INDIA
Approval Date
2024-03-27
Expiry Date
2029-03-26